{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:32:11Z","timestamp":1793644331315,"version":"4.5.1"},"reference-count":21,"publisher":"Massachusetts Medical Society","issue":"9","license":[{"start":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T00:00:00Z","timestamp":1693440000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.nejmgroup.org\/legal\/terms-of-use.htm"}],"funder":[{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","award":["Trial conduct, medical writing"],"award-info":[{"award-number":["Trial conduct, medical writing"]}],"id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["N Engl J Med"],"published-print":{"date-parts":[[2023,8,31]]},"DOI":"10.1056\/nejmoa2216455","type":"journal-article","created":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T17:00:51Z","timestamp":1693414851000},"page":"783-794","source":"Crossref","is-referenced-by-count":153,"title":["Phase 3 Trial of Concizumab in Hemophilia with Inhibitors"],"prefix":"10.1056","volume":"389","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3646-3125","authenticated-orcid":false,"given":"Tadashi","family":"Matsushita","sequence":"first","affiliation":[{"name":"From the Department of Transfusion Medicine, Nagoya University Hospital, Nagoya (T.M.), and Nara Medical University, Kashiwara (K.N.) \u2014 both in Japan; Indiana Hemophilia and Thrombosis Center, Indianapolis (A.S.); the Department of Hematology, Christian Medical College, Vellore, India (A.A.); the Division of Hematology, Department of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand (P.A.); the Center for Bleeding Disorders and Coagulation, Department of Oncology, Careggi University Hospital, Florence, Italy (G.C.); Novo Nordisk, S\u00f8borg, Denmark (K.C., J.H., S.H.J., J.S.R.); the Reference Center for Hemophilia and Rare Congenital Bleeding Disorders, Bic\u00eatre Hospital Assistance Publique\u2013H\u00f4pitaux de Paris, University of Paris-Saclay and UMR_S1176 INSERM, Le Kremlin-Bic\u00eatre, France (R.O.); the Department of Pediatrics, University of Texas Health Long School of Medicine, San Antonio (M.F.-J.); the Department of Medicine, Hospital Pulau Pinang, Georgetown, Malaysia (A.-S.G.); the Department ..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Shapiro","sequence":"additional","affiliation":[{"name":"From the Department of Transfusion Medicine, Nagoya University Hospital, Nagoya (T.M.), and Nara Medical University, Kashiwara (K.N.) \u2014 both in Japan; Indiana Hemophilia and Thrombosis Center, Indianapolis (A.S.); the Department of Hematology, Christian Medical College, Vellore, India (A.A.); the Division of Hematology, Department of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand (P.A.); the Center for Bleeding Disorders and Coagulation, Department of Oncology, Careggi University Hospital, Florence, Italy (G.C.); Novo Nordisk, S\u00f8borg, Denmark (K.C., J.H., S.H.J., J.S.R.); the Reference Center for Hemophilia and Rare Congenital Bleeding Disorders, Bic\u00eatre Hospital Assistance Publique\u2013H\u00f4pitaux de Paris, University of Paris-Saclay and UMR_S1176 INSERM, Le Kremlin-Bic\u00eatre, France (R.O.); the Department of Pediatrics, University of Texas Health Long School of Medicine, San Antonio (M.F.-J.); the Department of Medicine, Hospital Pulau Pinang, Georgetown, Malaysia (A.-S.G.); the Department ..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aby","family":"Abraham","sequence":"additional","affiliation":[{"name":"From the Department of Transfusion Medicine, Nagoya University Hospital, Nagoya (T.M.), and Nara Medical University, Kashiwara (K.N.) \u2014 both in Japan; Indiana Hemophilia and Thrombosis Center, Indianapolis (A.S.); the Department of Hematology, Christian Medical College, Vellore, India (A.A.); the Division of Hematology, Department of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand (P.A.); the Center for Bleeding Disorders and Coagulation, Department of Oncology, Careggi University Hospital, Florence, Italy (G.C.); Novo Nordisk, S\u00f8borg, Denmark (K.C., J.H., S.H.J., J.S.R.); the Reference Center for Hemophilia and Rare Congenital Bleeding Disorders, Bic\u00eatre Hospital Assistance Publique\u2013H\u00f4pitaux de Paris, University of Paris-Saclay and UMR_S1176 INSERM, Le Kremlin-Bic\u00eatre, France (R.O.); the Department of Pediatrics, University of Texas Health Long School of Medicine, San Antonio (M.F.-J.); the Department of Medicine, Hospital Pulau Pinang, Georgetown, Malaysia (A.-S.G.); the Department ..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pantep","family":"Angchaisuksiri","sequence":"additional","affiliation":[{"name":"From the Department of Transfusion Medicine, Nagoya University Hospital, Nagoya (T.M.), and Nara Medical University, Kashiwara (K.N.) \u2014 both in Japan; Indiana Hemophilia and Thrombosis Center, Indianapolis (A.S.); the Department of Hematology, Christian Medical College, Vellore, India (A.A.); the Division of Hematology, Department of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand (P.A.); the Center for Bleeding Disorders and Coagulation, Department of Oncology, Careggi University Hospital, Florence, Italy (G.C.); Novo Nordisk, S\u00f8borg, Denmark (K.C., J.H., S.H.J., J.S.R.); the Reference Center for Hemophilia and Rare Congenital Bleeding Disorders, Bic\u00eatre Hospital Assistance Publique\u2013H\u00f4pitaux de Paris, University of Paris-Saclay and UMR_S1176 INSERM, Le Kremlin-Bic\u00eatre, France (R.O.); the Department of Pediatrics, University of Texas Health Long School of Medicine, San Antonio (M.F.-J.); the Department of Medicine, Hospital Pulau Pinang, Georgetown, Malaysia (A.-S.G.); the Department ..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Castaman","sequence":"additional","affiliation":[{"name":"From the Department of Transfusion Medicine, Nagoya University Hospital, Nagoya (T.M.), and Nara Medical University, Kashiwara (K.N.) \u2014 both in Japan; Indiana Hemophilia and Thrombosis Center, Indianapolis (A.S.); the Department of Hematology, Christian Medical College, Vellore, India (A.A.); the Division of Hematology, Department of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand (P.A.); the Center for Bleeding Disorders and Coagulation, Department of Oncology, Careggi University Hospital, Florence, Italy (G.C.); Novo Nordisk, S\u00f8borg, Denmark (K.C., J.H., S.H.J., J.S.R.); the Reference Center for Hemophilia and Rare Congenital Bleeding Disorders, Bic\u00eatre Hospital Assistance Publique\u2013H\u00f4pitaux de Paris, University of Paris-Saclay and UMR_S1176 INSERM, Le Kremlin-Bic\u00eatre, France (R.O.); the Department of Pediatrics, University of Texas Health Long School of Medicine, San Antonio (M.F.-J.); the Department of Medicine, Hospital Pulau Pinang, Georgetown, Malaysia (A.-S.G.); the Department ..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarina","family":"Cepo","sequence":"additional","affiliation":[{"name":"From the Department of Transfusion Medicine, Nagoya University Hospital, Nagoya (T.M.), and Nara Medical University, Kashiwara (K.N.) \u2014 both in Japan; Indiana Hemophilia and Thrombosis Center, Indianapolis (A.S.); the Department of Hematology, Christian Medical College, Vellore, India (A.A.); the Division of Hematology, Department of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand (P.A.); the Center for Bleeding Disorders and Coagulation, Department of Oncology, Careggi University Hospital, Florence, Italy (G.C.); Novo Nordisk, S\u00f8borg, Denmark (K.C., J.H., S.H.J., J.S.R.); the Reference Center for Hemophilia and Rare Congenital Bleeding Disorders, Bic\u00eatre Hospital Assistance Publique\u2013H\u00f4pitaux de Paris, University of Paris-Saclay and UMR_S1176 INSERM, Le Kremlin-Bic\u00eatre, France (R.O.); the Department of Pediatrics, University of Texas Health Long School of Medicine, San Antonio (M.F.-J.); the Department of Medicine, Hospital Pulau Pinang, Georgetown, Malaysia (A.-S.G.); the Department ..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roseline","family":"d\u2019Oiron","sequence":"additional","affiliation":[{"name":"From the Department of Transfusion Medicine, Nagoya University Hospital, Nagoya (T.M.), and Nara Medical University, Kashiwara (K.N.) \u2014 both in Japan; Indiana Hemophilia and Thrombosis Center, Indianapolis (A.S.); the Department of Hematology, Christian Medical College, Vellore, India (A.A.); the Division of Hematology, Department of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand (P.A.); the Center for Bleeding Disorders and Coagulation, Department of Oncology, Careggi University Hospital, Florence, Italy (G.C.); Novo Nordisk, S\u00f8borg, Denmark (K.C., J.H., S.H.J., J.S.R.); the Reference Center for Hemophilia and Rare Congenital Bleeding Disorders, Bic\u00eatre Hospital Assistance Publique\u2013H\u00f4pitaux de Paris, University of Paris-Saclay and UMR_S1176 INSERM, Le Kremlin-Bic\u00eatre, France (R.O.); the Department of Pediatrics, University of Texas Health Long School of Medicine, San Antonio (M.F.-J.); the Department of Medicine, Hospital Pulau Pinang, Georgetown, Malaysia (A.-S.G.); the Department ..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Frei-Jones","sequence":"additional","affiliation":[{"name":"From the Department of Transfusion Medicine, Nagoya University Hospital, Nagoya (T.M.), and Nara Medical University, Kashiwara (K.N.) \u2014 both in Japan; Indiana Hemophilia and Thrombosis Center, Indianapolis (A.S.); the Department of Hematology, Christian Medical College, Vellore, India (A.A.); the Division of Hematology, Department of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand (P.A.); the Center for Bleeding Disorders and Coagulation, Department of Oncology, Careggi University Hospital, Florence, Italy (G.C.); Novo Nordisk, S\u00f8borg, Denmark (K.C., J.H., S.H.J., J.S.R.); the Reference Center for Hemophilia and Rare Congenital Bleeding Disorders, Bic\u00eatre Hospital Assistance Publique\u2013H\u00f4pitaux de Paris, University of Paris-Saclay and UMR_S1176 INSERM, Le Kremlin-Bic\u00eatre, France (R.O.); the Department of Pediatrics, University of Texas Health Long School of Medicine, San Antonio (M.F.-J.); the Department of Medicine, Hospital Pulau Pinang, Georgetown, Malaysia (A.-S.G.); the Department ..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai-Sim","family":"Goh","sequence":"additional","affiliation":[{"name":"From the Department of Transfusion Medicine, Nagoya University Hospital, Nagoya (T.M.), and Nara Medical University, Kashiwara (K.N.) \u2014 both in Japan; Indiana Hemophilia and Thrombosis Center, Indianapolis (A.S.); the Department of Hematology, Christian Medical College, Vellore, India (A.A.); the Division of Hematology, Department of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand (P.A.); the Center for Bleeding Disorders and Coagulation, Department of Oncology, Careggi University Hospital, Florence, Italy (G.C.); Novo Nordisk, S\u00f8borg, Denmark (K.C., J.H., S.H.J., J.S.R.); the Reference Center for Hemophilia and Rare Congenital Bleeding Disorders, Bic\u00eatre Hospital Assistance Publique\u2013H\u00f4pitaux de Paris, University of Paris-Saclay and UMR_S1176 INSERM, Le Kremlin-Bic\u00eatre, France (R.O.); the Department of Pediatrics, University of Texas Health Long School of Medicine, San Antonio (M.F.-J.); the Department of Medicine, Hospital Pulau Pinang, Georgetown, Malaysia (A.-S.G.); the Department ..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper","family":"Haaning","sequence":"additional","affiliation":[{"name":"From the Department of Transfusion Medicine, Nagoya University Hospital, Nagoya (T.M.), and Nara Medical University, Kashiwara (K.N.) \u2014 both in Japan; Indiana Hemophilia and Thrombosis Center, Indianapolis (A.S.); the Department of Hematology, Christian Medical College, Vellore, India (A.A.); the Division of Hematology, Department of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand (P.A.); the Center for Bleeding Disorders and Coagulation, Department of Oncology, Careggi University Hospital, Florence, Italy (G.C.); Novo Nordisk, S\u00f8borg, Denmark (K.C., J.H., S.H.J., J.S.R.); the Reference Center for Hemophilia and Rare Congenital Bleeding Disorders, Bic\u00eatre Hospital Assistance Publique\u2013H\u00f4pitaux de Paris, University of Paris-Saclay and UMR_S1176 INSERM, Le Kremlin-Bic\u00eatre, France (R.O.); the Department of Pediatrics, University of Texas Health Long School of Medicine, San Antonio (M.F.-J.); the Department of Medicine, Hospital Pulau Pinang, Georgetown, Malaysia (A.-S.G.); the Department ..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanja","family":"Hald Jacobsen","sequence":"additional","affiliation":[{"name":"From the Department of Transfusion Medicine, Nagoya University Hospital, Nagoya (T.M.), and Nara Medical University, Kashiwara (K.N.) \u2014 both in Japan; Indiana Hemophilia and Thrombosis Center, Indianapolis (A.S.); the Department of Hematology, Christian Medical College, Vellore, India (A.A.); the Division of Hematology, Department of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand (P.A.); the Center for Bleeding Disorders and Coagulation, Department of Oncology, Careggi University Hospital, Florence, Italy (G.C.); Novo Nordisk, S\u00f8borg, Denmark (K.C., J.H., S.H.J., J.S.R.); the Reference Center for Hemophilia and Rare Congenital Bleeding Disorders, Bic\u00eatre Hospital Assistance Publique\u2013H\u00f4pitaux de Paris, University of Paris-Saclay and UMR_S1176 INSERM, Le Kremlin-Bic\u00eatre, France (R.O.); the Department of Pediatrics, University of Texas Health Long School of Medicine, San Antonio (M.F.-J.); the Department of Medicine, Hospital Pulau Pinang, Georgetown, Malaysia (A.-S.G.); the Department ..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johnny","family":"Mahlangu","sequence":"additional","affiliation":[{"name":"From the Department of Transfusion Medicine, Nagoya University Hospital, Nagoya (T.M.), and Nara Medical University, Kashiwara (K.N.) \u2014 both in Japan; Indiana Hemophilia and Thrombosis Center, Indianapolis (A.S.); the Department of Hematology, Christian Medical College, Vellore, India (A.A.); the Division of Hematology, Department of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand (P.A.); the Center for Bleeding Disorders and Coagulation, Department of Oncology, Careggi University Hospital, Florence, Italy (G.C.); Novo Nordisk, S\u00f8borg, Denmark (K.C., J.H., S.H.J., J.S.R.); the Reference Center for Hemophilia and Rare Congenital Bleeding Disorders, Bic\u00eatre Hospital Assistance Publique\u2013H\u00f4pitaux de Paris, University of Paris-Saclay and UMR_S1176 INSERM, Le Kremlin-Bic\u00eatre, France (R.O.); the Department of Pediatrics, University of Texas Health Long School of Medicine, San Antonio (M.F.-J.); the Department of Medicine, Hospital Pulau Pinang, Georgetown, Malaysia (A.-S.G.); the Department ..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Mathias","sequence":"additional","affiliation":[{"name":"From the Department of Transfusion Medicine, Nagoya University Hospital, Nagoya (T.M.), and Nara Medical University, Kashiwara (K.N.) \u2014 both in Japan; Indiana Hemophilia and Thrombosis Center, Indianapolis (A.S.); the Department of Hematology, Christian Medical College, Vellore, India (A.A.); the Division of Hematology, Department of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand (P.A.); the Center for Bleeding Disorders and Coagulation, Department of Oncology, Careggi University Hospital, Florence, Italy (G.C.); Novo Nordisk, S\u00f8borg, Denmark (K.C., J.H., S.H.J., J.S.R.); the Reference Center for Hemophilia and Rare Congenital Bleeding Disorders, Bic\u00eatre Hospital Assistance Publique\u2013H\u00f4pitaux de Paris, University of Paris-Saclay and UMR_S1176 INSERM, Le Kremlin-Bic\u00eatre, France (R.O.); the Department of Pediatrics, University of Texas Health Long School of Medicine, San Antonio (M.F.-J.); the Department of Medicine, Hospital Pulau Pinang, Georgetown, Malaysia (A.-S.G.); the Department ..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Nogami","sequence":"additional","affiliation":[{"name":"From the Department of Transfusion Medicine, Nagoya University Hospital, Nagoya (T.M.), and Nara Medical University, Kashiwara (K.N.) \u2014 both in Japan; Indiana Hemophilia and Thrombosis Center, Indianapolis (A.S.); the Department of Hematology, Christian Medical College, Vellore, India (A.A.); the Division of Hematology, Department of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand (P.A.); the Center for Bleeding Disorders and Coagulation, Department of Oncology, Careggi University Hospital, Florence, Italy (G.C.); Novo Nordisk, S\u00f8borg, Denmark (K.C., J.H., S.H.J., J.S.R.); the Reference Center for Hemophilia and Rare Congenital Bleeding Disorders, Bic\u00eatre Hospital Assistance Publique\u2013H\u00f4pitaux de Paris, University of Paris-Saclay and UMR_S1176 INSERM, Le Kremlin-Bic\u00eatre, France (R.O.); the Department of Pediatrics, University of Texas Health Long School of Medicine, San Antonio (M.F.-J.); the Department of Medicine, Hospital Pulau Pinang, Georgetown, Malaysia (A.-S.G.); the Department ..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine","family":"Skovgaard Rasmussen","sequence":"additional","affiliation":[{"name":"From the Department of Transfusion Medicine, Nagoya University Hospital, Nagoya (T.M.), and Nara Medical University, Kashiwara (K.N.) \u2014 both in Japan; Indiana Hemophilia and Thrombosis Center, Indianapolis (A.S.); the Department of Hematology, Christian Medical College, Vellore, India (A.A.); the Division of Hematology, Department of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand (P.A.); the Center for Bleeding Disorders and Coagulation, Department of Oncology, Careggi University Hospital, Florence, Italy (G.C.); Novo Nordisk, S\u00f8borg, Denmark (K.C., J.H., S.H.J., J.S.R.); the Reference Center for Hemophilia and Rare Congenital Bleeding Disorders, Bic\u00eatre Hospital Assistance Publique\u2013H\u00f4pitaux de Paris, University of Paris-Saclay and UMR_S1176 INSERM, Le Kremlin-Bic\u00eatre, France (R.O.); the Department of Pediatrics, University of Texas Health Long School of Medicine, San Antonio (M.F.-J.); the Department of Medicine, Hospital Pulau Pinang, Georgetown, Malaysia (A.-S.G.); the Department ..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleksandra","family":"Stasyshyn","sequence":"additional","affiliation":[{"name":"From the Department of Transfusion Medicine, Nagoya University Hospital, Nagoya (T.M.), and Nara Medical University, Kashiwara (K.N.) \u2014 both in Japan; Indiana Hemophilia and Thrombosis Center, Indianapolis (A.S.); the Department of Hematology, Christian Medical College, Vellore, India (A.A.); the Division of Hematology, Department of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand (P.A.); the Center for Bleeding Disorders and Coagulation, Department of Oncology, Careggi University Hospital, Florence, Italy (G.C.); Novo Nordisk, S\u00f8borg, Denmark (K.C., J.H., S.H.J., J.S.R.); the Reference Center for Hemophilia and Rare Congenital Bleeding Disorders, Bic\u00eatre Hospital Assistance Publique\u2013H\u00f4pitaux de Paris, University of Paris-Saclay and UMR_S1176 INSERM, Le Kremlin-Bic\u00eatre, France (R.O.); the Department of Pediatrics, University of Texas Health Long School of Medicine, San Antonio (M.F.-J.); the Department of Medicine, Hospital Pulau Pinang, Georgetown, Malaysia (A.-S.G.); the Department ..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huyen","family":"Tran","sequence":"additional","affiliation":[{"name":"From the Department of Transfusion Medicine, Nagoya University Hospital, Nagoya (T.M.), and Nara Medical University, Kashiwara (K.N.) \u2014 both in Japan; Indiana Hemophilia and Thrombosis Center, Indianapolis (A.S.); the Department of Hematology, Christian Medical College, Vellore, India (A.A.); the Division of Hematology, Department of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand (P.A.); the Center for Bleeding Disorders and Coagulation, Department of Oncology, Careggi University Hospital, Florence, Italy (G.C.); Novo Nordisk, S\u00f8borg, Denmark (K.C., J.H., S.H.J., J.S.R.); the Reference Center for Hemophilia and Rare Congenital Bleeding Disorders, Bic\u00eatre Hospital Assistance Publique\u2013H\u00f4pitaux de Paris, University of Paris-Saclay and UMR_S1176 INSERM, Le Kremlin-Bic\u00eatre, France (R.O.); the Department of Pediatrics, University of Texas Health Long School of Medicine, San Antonio (M.F.-J.); the Department of Medicine, Hospital Pulau Pinang, Georgetown, Malaysia (A.-S.G.); the Department ..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kateryna","family":"Vilchevska","sequence":"additional","affiliation":[{"name":"From the Department of Transfusion Medicine, Nagoya University Hospital, Nagoya (T.M.), and Nara Medical University, Kashiwara (K.N.) \u2014 both in Japan; Indiana Hemophilia and Thrombosis Center, Indianapolis (A.S.); the Department of Hematology, Christian Medical College, Vellore, India (A.A.); the Division of Hematology, Department of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand (P.A.); the Center for Bleeding Disorders and Coagulation, Department of Oncology, Careggi University Hospital, Florence, Italy (G.C.); Novo Nordisk, S\u00f8borg, Denmark (K.C., J.H., S.H.J., J.S.R.); the Reference Center for Hemophilia and Rare Congenital Bleeding Disorders, Bic\u00eatre Hospital Assistance Publique\u2013H\u00f4pitaux de Paris, University of Paris-Saclay and UMR_S1176 INSERM, Le Kremlin-Bic\u00eatre, France (R.O.); the Department of Pediatrics, University of Texas Health Long School of Medicine, San Antonio (M.F.-J.); the Department of Medicine, Hospital Pulau Pinang, Georgetown, Malaysia (A.-S.G.); the Department ..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Villarreal Martinez","sequence":"additional","affiliation":[{"name":"From the Department of Transfusion Medicine, Nagoya University Hospital, Nagoya (T.M.), and Nara Medical University, Kashiwara (K.N.) \u2014 both in Japan; Indiana Hemophilia and Thrombosis Center, Indianapolis (A.S.); the Department of Hematology, Christian Medical College, Vellore, India (A.A.); the Division of Hematology, Department of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand (P.A.); the Center for Bleeding Disorders and Coagulation, Department of Oncology, Careggi University Hospital, Florence, Italy (G.C.); Novo Nordisk, S\u00f8borg, Denmark (K.C., J.H., S.H.J., J.S.R.); the Reference Center for Hemophilia and Rare Congenital Bleeding Disorders, Bic\u00eatre Hospital Assistance Publique\u2013H\u00f4pitaux de Paris, University of Paris-Saclay and UMR_S1176 INSERM, Le Kremlin-Bic\u00eatre, France (R.O.); the Department of Pediatrics, University of Texas Health Long School of Medicine, San Antonio (M.F.-J.); the Department of Medicine, Hospital Pulau Pinang, Georgetown, Malaysia (A.-S.G.); the Department ..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerzy","family":"Windyga","sequence":"additional","affiliation":[{"name":"From the Department of Transfusion Medicine, Nagoya University Hospital, Nagoya (T.M.), and Nara Medical University, Kashiwara (K.N.) \u2014 both in Japan; Indiana Hemophilia and Thrombosis Center, Indianapolis (A.S.); the Department of Hematology, Christian Medical College, Vellore, India (A.A.); the Division of Hematology, Department of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand (P.A.); the Center for Bleeding Disorders and Coagulation, Department of Oncology, Careggi University Hospital, Florence, Italy (G.C.); Novo Nordisk, S\u00f8borg, Denmark (K.C., J.H., S.H.J., J.S.R.); the Reference Center for Hemophilia and Rare Congenital Bleeding Disorders, Bic\u00eatre Hospital Assistance Publique\u2013H\u00f4pitaux de Paris, University of Paris-Saclay and UMR_S1176 INSERM, Le Kremlin-Bic\u00eatre, France (R.O.); the Department of Pediatrics, University of Texas Health Long School of Medicine, San Antonio (M.F.-J.); the Department of Medicine, Hospital Pulau Pinang, Georgetown, Malaysia (A.-S.G.); the Department ..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chur Woo","family":"You","sequence":"additional","affiliation":[{"name":"From the Department of Transfusion Medicine, Nagoya University Hospital, Nagoya (T.M.), and Nara Medical University, Kashiwara (K.N.) \u2014 both in Japan; Indiana Hemophilia and Thrombosis Center, Indianapolis (A.S.); the Department of Hematology, Christian Medical College, Vellore, India (A.A.); the Division of Hematology, Department of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand (P.A.); the Center for Bleeding Disorders and Coagulation, Department of Oncology, Careggi University Hospital, Florence, Italy (G.C.); Novo Nordisk, S\u00f8borg, Denmark (K.C., J.H., S.H.J., J.S.R.); the Reference Center for Hemophilia and Rare Congenital Bleeding Disorders, Bic\u00eatre Hospital Assistance Publique\u2013H\u00f4pitaux de Paris, University of Paris-Saclay and UMR_S1176 INSERM, Le Kremlin-Bic\u00eatre, France (R.O.); the Department of Pediatrics, University of Texas Health Long School of Medicine, San Antonio (M.F.-J.); the Department of Medicine, Hospital Pulau Pinang, Georgetown, Malaysia (A.-S.G.); the Department ..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadezhda","family":"Zozulya","sequence":"additional","affiliation":[{"name":"From the Department of Transfusion Medicine, Nagoya University Hospital, Nagoya (T.M.), and Nara Medical University, Kashiwara (K.N.) \u2014 both in Japan; Indiana Hemophilia and Thrombosis Center, Indianapolis (A.S.); the Department of Hematology, Christian Medical College, Vellore, India (A.A.); the Division of Hematology, Department of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand (P.A.); the Center for Bleeding Disorders and Coagulation, Department of Oncology, Careggi University Hospital, Florence, Italy (G.C.); Novo Nordisk, S\u00f8borg, Denmark (K.C., J.H., S.H.J., J.S.R.); the Reference Center for Hemophilia and Rare Congenital Bleeding Disorders, Bic\u00eatre Hospital Assistance Publique\u2013H\u00f4pitaux de Paris, University of Paris-Saclay and UMR_S1176 INSERM, Le Kremlin-Bic\u00eatre, France (R.O.); the Department of Pediatrics, University of Texas Health Long School of Medicine, San Antonio (M.F.-J.); the Department of Medicine, Hospital Pulau Pinang, Georgetown, Malaysia (A.-S.G.); the Department ..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bulent","family":"Zulfikar","sequence":"additional","affiliation":[{"name":"From the Department of Transfusion Medicine, Nagoya University Hospital, Nagoya (T.M.), and Nara Medical University, Kashiwara (K.N.) \u2014 both in Japan; Indiana Hemophilia and Thrombosis Center, Indianapolis (A.S.); the Department of Hematology, Christian Medical College, Vellore, India (A.A.); the Division of Hematology, Department of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand (P.A.); the Center for Bleeding Disorders and Coagulation, Department of Oncology, Careggi University Hospital, Florence, Italy (G.C.); Novo Nordisk, S\u00f8borg, Denmark (K.C., J.H., S.H.J., J.S.R.); the Reference Center for Hemophilia and Rare Congenital Bleeding Disorders, Bic\u00eatre Hospital Assistance Publique\u2013H\u00f4pitaux de Paris, University of Paris-Saclay and UMR_S1176 INSERM, Le Kremlin-Bic\u00eatre, France (R.O.); the Department of Pediatrics, University of Texas Health Long School of Medicine, San Antonio (M.F.-J.); the Department of Medicine, Hospital Pulau Pinang, Georgetown, Malaysia (A.-S.G.); the Department ..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Jim\u00e9nez-Yuste","sequence":"additional","affiliation":[{"name":"From the Department of Transfusion Medicine, Nagoya University Hospital, Nagoya (T.M.), and Nara Medical University, Kashiwara (K.N.) \u2014 both in Japan; Indiana Hemophilia and Thrombosis Center, Indianapolis (A.S.); the Department of Hematology, Christian Medical College, Vellore, India (A.A.); the Division of Hematology, Department of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand (P.A.); the Center for Bleeding Disorders and Coagulation, Department of Oncology, Careggi University Hospital, Florence, Italy (G.C.); Novo Nordisk, S\u00f8borg, Denmark (K.C., J.H., S.H.J., J.S.R.); the Reference Center for Hemophilia and Rare Congenital Bleeding Disorders, Bic\u00eatre Hospital Assistance Publique\u2013H\u00f4pitaux de Paris, University of Paris-Saclay and UMR_S1176 INSERM, Le Kremlin-Bic\u00eatre, France (R.O.); the Department of Pediatrics, University of Texas Health Long School of Medicine, San Antonio (M.F.-J.); the Department of Medicine, Hospital Pulau Pinang, Georgetown, Malaysia (A.-S.G.); the Department ..."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"150","reference":[{"key":"e_1_3_5_2_2","first-page":"1","volume-title":"Haemophilia","author":"Srivastava A","year":"2020","unstructured":"Srivastava A, Santagostino E, Dougall A, et al. WFH guidelines for the management of hemophilia, 3rd edition. Haemophilia 2020;26:Suppl 6:1-158.32744769"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2008.01843.x"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.12328"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/hae.13111"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019000658"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14296"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S139851"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2019.11.006"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-07-820712"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-01-401620"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/jth.15697"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14272"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019001542"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021006403"},{"key":"e_1_3_5_16_2","first-page":"124","article-title":"Risk mitigation strategy for concizumab clinical trials re-initiation after pause due to non-fatal thrombotic events.","volume":"27","author":"Seremetis S","year":"2021","unstructured":"Seremetis S, Cepo K, Rasmussen J, et al. Risk mitigation strategy for concizumab clinical trials re-initiation after pause due to non-fatal thrombotic events. Haemophilia 2021;27:Suppl 2:124-124. abstract.","journal-title":"Haemophilia"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-139563"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics10060365"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.2135"},{"key":"e_1_3_5_20_2","first-page":"443","article-title":"Never ignore extremely elevated D-dimer levels: they are specific for serious illness.","volume":"74","author":"Schutte T","year":"2016","unstructured":"Schutte T, Thijs A, Smulders YM. Never ignore extremely elevated D-dimer levels: they are specific for serious illness. Neth J Med 2016;74:443-448.27966438","journal-title":"Neth J Med"},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01951"},{"key":"e_1_3_5_22_2","unstructured":"Report on the Annual Global Survey 2020. Montreal: World Federation of Hemophilia October 2021 (https:\/\/www1.wfh.org\/publications\/files\/pdf-2045.pdf)."}],"container-title":["New England Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nejm.org\/doi\/pdf\/10.1056\/NEJMoa2216455","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T18:55:17Z","timestamp":1749668117000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nejm.org\/doi\/10.1056\/NEJMoa2216455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,31]]},"references-count":21,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,8,31]]}},"alternative-id":["10.1056\/NEJMoa2216455"],"URL":"https:\/\/doi.org\/10.1056\/nejmoa2216455","relation":{},"ISSN":["0028-4793","1533-4406"],"issn-type":[{"value":"0028-4793","type":"print"},{"value":"1533-4406","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,31]]}}}